文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

澳大利亚老年成年人的代谢健康、超重或肥胖与肺功能

Metabolic Health, Overweight or Obesity, and Lung Function in Older Australian Adults.

作者信息

Opio Jacob, Wynne Katie, Attia John, Hancock Stephen, McEvoy Mark

机构信息

School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.

Diabetes and Endocrinology, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.

出版信息

Nutrients. 2024 Dec 10;16(24):4256. doi: 10.3390/nu16244256.


DOI:10.3390/nu16244256
PMID:39770878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11676256/
Abstract

Few studies have explored the links between adiposity, metabolic health, and lung function. This study examined the cross-sectional association between spirometric lung function and overweight/obesity, with and without metabolic abnormalities, in older adults. The research involved 3,318 older adults from the Hunter Community Study Cohort who had a BMI of 18.5 kg/m or higher. Participants were grouped based on BMI and metabolic health risk. Obesity was defined as a BMI of 30 kg/m or more, while metabolic health was determined by the absence of risk factors according to the International Diabetes Federation criteria. Lung function was assessed via spirometry, measuring FEV1, FVC, predicted FEV1, predicted FVC, and FEV1/FVC ratio. Lung dysfunction was classified into restrictive, obstructive, mixed patterns, and deviations from predicted FEV1 and FVC. The mean lung function measurements were as follows: FEV1 2.4 L (0.7), FVC 2.9 L (0.8), predicted FEV1% 88.7% (17.6), predicted FVC% 85.6% (15.7), and FEV1/FVC 82.5% (8.5). Compared to the metabolically healthy normal weight (MHNW) group, the odds of lung dysfunction were as follows. For the restrictive pattern, the MHOW group had an odds ratio (OR) of 1.00 (95% CI: 0.70-1.47, = 0.959) and the MHO group had an OR of 1.67 (95% CI: 1.13-2.49, = 0.011). For the obstructive pattern, the MHOW group had an OR of 0.39 (95% CI: 0.20-0.77, = 0.007) and the MHO group had an OR of 0.36 (95% CI: 0.12-1.05, = 0.061). For the mixed pattern, the MHOW group had an OR of 0.39 (95% CI: 0.18-0.87, = 0.021) and the MHO group had an OR of 0.29 (95% CI: 0.10-0.87, = 0.027). A higher BMI and variations in metabolic health are associated with an increased likelihood of restrictive lung function patterns. Conversely, obesity is inversely related to obstructive lung function patterns.

摘要

很少有研究探讨肥胖、代谢健康和肺功能之间的联系。本研究调查了老年人中肺活量测定的肺功能与超重/肥胖之间的横断面关联,无论是否存在代谢异常。该研究涉及来自亨特社区研究队列的3318名老年人,他们的体重指数(BMI)为18.5千克/平方米或更高。参与者根据BMI和代谢健康风险进行分组。肥胖定义为BMI为30千克/平方米或更高,而代谢健康则根据国际糖尿病联合会的标准,通过不存在风险因素来确定。通过肺活量测定评估肺功能,测量第一秒用力呼气容积(FEV1)、用力肺活量(FVC)、预测FEV1、预测FVC以及FEV1/FVC比值。肺功能障碍分为限制性、阻塞性、混合性模式以及与预测FEV1和FVC的偏差。肺功能测量的平均值如下:FEV1为2.4升(0.7),FVC为2.9升(0.8),预测FEV1%为88.7%(17.6),预测FVC%为85.6%(15.7),FEV1/FVC为82.5%(8.5)。与代谢健康的正常体重(MHNW)组相比,肺功能障碍的比值比(OR)如下。对于限制性模式,超重/肥胖但代谢健康(MHOW)组的OR为1.00(95%置信区间:0.70 - 1.47,P = 0.959),肥胖且代谢健康(MHO)组的OR为1.67(95%置信区间:1.13 - 2.49,P = 0.011)。对于阻塞性模式,MHOW组的OR为0.39(95%置信区间:0.20 - 0.77,P = 0.007),MHO组的OR为0.36(95%置信区间:0.12 - 1.05,P = 0.061)。对于混合性模式,MHOW组的OR为0.39(95%置信区间:0.18 - 0.87,P = 0.021),MHO组的OR为0.29(95%置信区间:0.10 - 0.87,P = 0.027)。较高的BMI和代谢健康的变化与限制性肺功能模式的可能性增加有关。相反,肥胖与阻塞性肺功能模式呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb1/11676256/de64fa2c486c/nutrients-16-04256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb1/11676256/9cfafee0e9e4/nutrients-16-04256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb1/11676256/de64fa2c486c/nutrients-16-04256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb1/11676256/9cfafee0e9e4/nutrients-16-04256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb1/11676256/de64fa2c486c/nutrients-16-04256-g002.jpg

相似文献

[1]
Metabolic Health, Overweight or Obesity, and Lung Function in Older Australian Adults.

Nutrients. 2024-12-10

[2]
Association of adiposity with pulmonary function in older Chinese: Guangzhou Biobank Cohort Study.

Respir Med. 2017-10-7

[3]
The effects of body mass index on spirometry tests among adults in Xi'an, China.

Medicine (Baltimore). 2017-4

[4]
Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study.

COPD. 2015-2

[5]
Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Am J Kidney Dis. 2017-11

[6]
Metabolic Health, Overweight or Obesity, and Depressive Symptoms among Older Australian Adults.

Nutrients. 2024-3-23

[7]
Respiratory Function Correlates with Fat Mass Index and Blood Triglycerides in Institutionalized Older Individuals.

Endocr Metab Immune Disord Drug Targets. 2022

[8]
Association of pulmonary function with adiposity and metabolic abnormalities in urban minority adolescents.

Ann Am Thorac Soc. 2014-6

[9]
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.

JAMA. 2021-12-14

[10]
The Relationship Between BMI and Lung Function in Populations with Different Characteristics: A Cross-Sectional Study Based on the Enjoying Breathing Program in China.

Int J Chron Obstruct Pulmon Dis. 2022

引用本文的文献

[1]
Associations Between Metabolic Risk Factors and Lung Function Among Adults in Northern Thailand: A Cross-Sectional Study.

Healthcare (Basel). 2025-7-10

本文引用的文献

[1]
Relationship between commonly defined metabolic health phenotypes and obesity with lung function in a working population: A cross-sectional study.

Heart Lung. 2024

[2]
Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.

Obes Pillars. 2022-1-15

[3]
The Impact of Metabolic Syndrome Risk Factors on Lung Function Impairment: Cross-Sectional Study.

JMIR Public Health Surveill. 2023-9-5

[4]
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.

EClinicalMedicine. 2023-5

[5]
Metabolically healthy and unhealthy obesity and the development of lung dysfunction.

Sci Rep. 2023-3-27

[6]
Longitudinal association between adiposity changes and lung function deterioration.

Respir Res. 2023-2-7

[7]
A review of current guidelines for the treatment of obesity.

Am J Manag Care. 2022-12

[8]
The Related Metabolic Diseases and Treatments of Obesity.

Healthcare (Basel). 2022-8-25

[9]
Pulmonary Function in Metabolic Syndrome: A Meta-Analysis.

Metab Syndr Relat Disord. 2022-12

[10]
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.

Metabolism. 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索